Journals / Haseki Tıp Bülteni / 2020 / Cilt: 58 - Sayı: 3

Demographic, Clinicopathological and Laboratory Features of Focal Segmental Glomerulosclerosis Patients

Fokal Segmental Glomerüloskleroz Hastalarının Demografik, Klinikopatolojik ve Laboratuvar Özellikleri

Pages
245–250
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Biopsy should be considered earlier in patients suspected of FSGS, as tubular atrophy and interstitial fibrosis rates were high in biopsies.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Focal segmental glomerulosclerosis (FSGS) is one of the common glomerulonephritis in Turkey and the world.
📊
Key Findings & Data:Results: Fifty-nine patients (59.6%) were women.
💡
Conclusion & Impact:Biopsy should be considered earlier in patients suspected of FSGS, as tubular atrophy and interstitial fibrosis rates were high in biopsies.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: Focal segmental glomerulosclerosis (FSGS) is one of the common glomerulonephritis in Turkey and the world. The aim of our study was to determine demographic and clinical features and biopsy results of patients who were followed up with primary FSGS in our center. Methods: Ninety-nine adult patients with FSGS diagnosed via renal biopsy, who were followed up in our outpatient clinic, were included in our single-center, retrospective, cross-sectional study. Patients with secondary FSGS were excluded. Demographic and clinical features and biopsy results were examined retrospectively. Results: Fifty-nine patients (59.6%) were women. Nephrotic syndrome was the most common biopsy indication (68.7%) and the mean estimated glomerular filtration rate at presentation was 78.9±35.8 mL/min/1.73 m2. The mean serum albumin level was 3.2±0.9 g/dL and urine protein level was 3485 mg/day (interquartile range: 1739-7275). Interstitial fibrosis was detected in 63.4% and tubular atrophy in 74.7% of patients. Conclusion: The complaints and clinical data of our patients with FSGS were similar with the country and world data. Approximately 40% of the patients presented with decreased renal functions at the time of biopsy. Biopsy should be considered earlier in patients suspected of FSGS, as tubular atrophy and interstitial fibrosis rates were high in biopsies.

Özet

Amaç: Fokal segmental glomerüloskleroz (FSGS) Türkiye’ de ve dünyada sık görülen glomerülonefritlerdendir. Çalışmamızın amacı, merkezimizde erişkin yaş grubunda primer FSGS tanısıyla takip edilmekte olan hastaların tanı anı demografik ve klinik özelliklerini, biyopsi bulgularını ortaya koymaktır. Yöntemler: Tek merkezli, retrospektif, kesitsel çalışmamıza kliniğimizde takip edilen böbrek biyopsi ile kanıtlanmış primer FSGS tanılı 99 erişkin hasta çalışmamıza dahil edildi. Sekonder FSGS tanılı hastalar dışlandı. Hastalara ait demografik ve klinik özellikleri, biyopsi bulguları incelendi. Bulgular: Çalışmamıza dahil edilen 99 hastadan 59’u (%59,6) kadındı. Hastaların ortalama tanı yaşı 40,7±13,8 yıldı. Hastaların en sık biyopsi endikasyonu nefrotik sendromdu (%68,7), başvuru tahmini glomerüler filtrasyon hızı 78,9±35,8 mL/dk/1,73 m2’ydi. Serum albümin ortalamaları 3,2±0,9 gr/dL iken, proteinüri ortancaları 3485 (çeyrekler arası Aralık: 1739-7275) mg/gün olarak saptandı. İnterstisyel fibrozis hastaların %63,4’ünde, tübüler atrofi %74,7’sinde saptandı. Sonuç: Fokal segmental glomerüloskleroz hastalarımızda başvuru şikayetleri ve klinik verileri ülke ve dünya literatürü ile uyumlu bulunmakla birlikte biyopsi anında hastaların yaklaşık yüzde kırkı azalmış böbrek fonksiyonlarıyla karşımıza çıkmaktadır. Yapılan biyopsilerde tübüler atrofi ve interstisyel fibrozisin yüksek oranda görülmesi nedeniyle FSGS düşünülen hastaların biyopsileri daha erken yapılmalıdır.

🔖

Cite This Article

ÖZLER, T. E. Ş., CEYLAN, Ö. C., CEBECİ, E., UZUN, S., KARADAĞ, S., ÖZKAN, O., BAŞHAN, Y., DAĞ, H. B., KARAALİ, Z., OZTURK, S. (2020). Demographic, Clinicopathological and Laboratory Features of Focal Segmental Glomerulosclerosis Patients. Haseki Tıp Bülteni, Cilt: 58 - Sayı: 3, 245–250. https://ajindex.com/articles/158583

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Ozturk S, Sumnu A, Seyahi N, ve ark. Demographic and clinical characteristics of primary glomerular diseases in Turkey. Int Urol Nephrol 2014;46:2347-55
  2. Haas M, Meehan SM, Karrison TG, Spargo BH. Changing etiologies of unexplained adult nephrotic syndrome: a comparison of renal biopsy findings from 1976-1979 and 1995-1997. Am J Kidney Dis 1997;30:621-31
  3. Hommos MS, De Vriese AS, Alexander MP, ve ark. The Incidence of Primary vs Secondary Focal Segmental Glomerulosclerosis. A Clinicopathologic Study Mayo Clin Proc 2017; 92:1772-81
  4. Kitiyakara C, Eggers P, Kopp JB. Twenty-one-year trend in ESRD due to focal segmental glomerulosclerosis in the United States. Am J Kidney Dis 2004;44:815-25
  5. Crew RJ, Appel GB. Focal segmental glomerulosclerosis. In Greenberg A, ed. The NKF Primer on Kidney Disease, 4th ed. Philadelphia, Elsevier 2005; 178-82
  6. Chun MJ, Korbet SM, Schwartz MM, Lewis EJ. Focal segmental glomerulosclerosis in nephrotic adults: presentation, prognosis, and response to therapy of the histologic variants. J Am Soc Nephrol 2004;15:2169-77
  7. Deegens JK, Steenbergen EJ, Wetzels JF. Review on diagnosis and treatment of focal segmental glomerulosclerosis. Neth J Med 2008;66:3-12
  8. Deegens JK, Dijkman HB, Borm GF, ve ark. Podocyte foot process effacement as a diagnostic tool in focal segmental glomerulosclerosis. Kidney Int 2008;74:1568-76
  9. Rydel JJ, Korbet SM, Borok RZ, Schwartz MM. Focal segmental glomerular sclerosis in adults: Presentation, course, and response to treatment. Am J Kidney Dis 1995;25:534-42
  10. Cattran DC, Rao P. Long-term outcome in children and adults with classic focal segmental glomerulosclerosis. Am J Kidney Dis 1998;32:72-9
  11. Pokhariyal S, Gulati S, Prasad N, ve ark. Duration of optimal therapy for idiopathic focal segmental glomerulosclerosis. J Nephrol 2003;16:691-6
  12. Crook ED, Habeeb D, Gowdy O, Nimmagadda S, Salem M. Effects of steroids in focal segmental glomerulosclerosis in a predominantly African-American population. Am J Med Sci 2005;330:19-24
  13. Thomas DB, Franceschini N, Hogan SL, ve ark. Clinical and pathologic characteristics of focal segmental glomerulosclerosis pathologic variants. Kidney Int 2006;69:920-6
  14. Sethi S, Zand L, Nasr SH, Glassock RJ, Fervenza FC. Focal and segmental glomerulosclerosis: clinical and kidney biopsy correlations. Clin Kidney J 2014;7:531-7
  15. Kambham N, Markowitz GS, Valeri AM, Lin J, D’Agati VD. Obesity-related glomerulopathy: an emerging epidemic. Kid